You are here: All Products  > Everest’s In-licensed Kidney Drug Meets Endpoints in Phase III Trial

Everest’s In-licensed Kidney Drug Meets Endpoints in Phase III Trial

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products